Scientists hunt for clues to predict blistering disease severity
NCT ID NCT07649486
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 50 people with bullous pemphigoid, a skin condition that causes blisters. Researchers want to see if certain proteins in skin samples and blood markers like IgE and eosinophil counts are linked to how severe the disease is. The goal is to find better ways to measure disease activity, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and monitor disease activity in bullous pemphigoid using tissue or blood markers.
- What could go wrong
- This is a small, observational study that does not test a treatment. The findings may not lead to immediate changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BULLOUS PEMPHIGOID (BP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
S.B.Ü. İstanbul Eğitim ve Araştırma Hastanesi
Istanbul, FATİH, 34096, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.